CME Group stock: Morgan Stanley raises target for CME Group stock to USD 337.00
Published on 10/20/2026 at 16:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and trading activity
- Morgan Stanley raised its CME Group target from USD 330.00 to USD 337.00 on October 9, 2026.
- September dairy open interest averaged 420,922 contracts, up 42 percent year over year.
- CME Group stock costs EUR 263.55 at Lang & Schwarz on October 20, 2026 at 4:39 p.m. CEST.
CME Group stock: Morgan Stanley raised its price target for CME Group from USD 330.00 to USD 337.00 on October 9, 2026, while maintaining an Overweight rating, according to Benzinga. The new target is 14.16 percent above CME Group's USD 295.14 Nasdaq price on October 20, 2026 at 10:52 a.m. ET. CME Group was trading at EUR 263.55 at Lang & Schwarz on October 20, 2026 at 4:39 p.m. CEST.
European dairy expansion adds volume context
CME Group announced plans on October 19, 2026 to launch European futures and options for skimmed milk powder, butter, whey powder and liquid milk before the end of 2026, subject to regulatory reviews. The announcement followed September average daily open interest of 420,922 dairy contracts, up 42 percent from the prior year, according to MarketScreener.
Price position remains measurable
The Nasdaq price of USD 295.14 on October 20, 2026 stood within the 52-week range of USD 218.31 to USD 329.16. The same quote carried a market capitalization of USD 106.1 billion, a price-to-earnings ratio of 25.10 and volume of 611,022 shares. These figures place CME Group 10.34 percent below its 52-week high, calculated from the USD 295.14 price and the USD 329.16 high.
Results date and valuation guide attention
CME Group is scheduled to report third-quarter 2026 results before the opening bell on October 21, 2026, according to Benzinga. Consensus estimates cited by the publication call for USD 2.98 earnings per share and USD 1.71 billion in revenue, compared with USD 2.68 earnings per share and USD 1.54 billion in revenue in the year-ago quarter.
For the reported second quarter of 2026, CME Group generated USD 1.71 billion in revenue and USD 1.04 billion in net income, with a 61 percent net margin. The period ended June 30, 2026, according to the company's standardized financial statements.
What the target means for valuation
Morgan Stanley's USD 337.00 target sits above the current Nasdaq price, but it is not a forecast from CME Group itself. The upcoming results will provide the next dated test of revenue growth, earnings and trading activity.
Stock price and next milestone
CME Group stock was trading at EUR 263.55 at Lang & Schwarz on October 20, 2026 at 4:39 p.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of CME Group stock.
CME Group stock facts
- Company: CME Group Inc.
- ISIN: US12572Q1058
- WKN: A0MW32
- Ticker: CME
- Primary exchange: Nasdaq
- Price Lang & Schwarz as of October 20, 2026, 4:39 p.m. CEST: EUR 263.55
- Market capitalization: USD 106.1 billion (as of October 20, 2026)
- Sector / Industry: Financial Services / Financial - Data and Stock Exchanges
- Next earnings date: October 21, 2026
Market context: Market report S&P 500.
